MEDI 475-Discovery of orally active met kinase inhibitors

被引：0

作者：

Cai, Zhen-wei ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Bristol Myers Squibb R&D, Discovery Chem, Princeton, NJ 08543 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

475-MEDI

引用

页数：1

共 50 条

[21] Discovery of orally active selective inhibitors of Plk1[p]
Pinder, Joanne L.
Durrant, Steven
Everitt, Simon
Mortimore, Michael
Keily, Shazia
Knegtel, Ronald
O'Donnell, Michael
Brenchley, Guy
Charrier, Jean-Damien
Golec, Julian
Kay, David
Mak, Chau
Ramaya, Sharn
Rutherford, Alistair
Studley, John
Virani, Anisa
Weber, Peter
Young, Stephen C.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[22] Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors
Velcicky, Juraj
Mathison, Casey J. N.
Nikulin, Victor
Pflieger, Daniel
Epple, Robert
Azimioara, Mihai
Cow, Christopher
Michellys, Pierre-Yves
Rigollier, Pascal
Beisner, Daniel R.
Bodendorf, Ursula
Guerini, Danilo
Liu, Bo
Wen, Ben
Zaharevitz, Samantha
Brandl, Trixi
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (06): : 887 - 892
[23] Discovery of orally active butyrolactam 11β-HSD1 inhibitors
Yeh, Vince S. C.
Kurukulasuriya, Ravi
Fung, Steven
Monzon, Katina
Chiou, William
Wang, Jiahong
Stolarik, Deanne
Imade, Hovis
Shapiro, Robin
Knourek-Segel, Victoria
Bush, Eugene
Wilcox, Denise
Nguyen, Phong T.
Brune, Michael
Jacobson, Peer
Link, J. T.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (21) : 5555 - 5560
[24] Discovery of new orally active phosphodiesterase (PDE4) inhibitors
Ochiai, H
Ishida, A
Ohtani, T
Kusumi, K
Kishikawa, K
Yamamoto, S
Takeda, H
Obata, T
Nakai, H
Toda, M
CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (09) : 1098 - 1104
[25] Discovery of potent and orally active tricyclic-based FBPase inhibitors
Tsukada, Tomoharu
Kanno, Osamu
Yamane, Takahiro
Tanaka, Jun
Yoshida, Taishi
Okuno, Akira
Shiiki, Takeshi
Takahashi, Mizuki
Nishi, Takahide
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5346 - 5351
[26] Discovery of sulfonylalkylamides: A new class of orally active factor Xa inhibitors
Imaeda, Yasuhiro
Miyawaki, Toshio
Sakamoto, Hiroki
Itoh, Fumio
Konishi, Noriko
Hiroe, Katsuhiko
Kawamura, Masaki
Tanaka, Toshimasa
Kubo, Keiji
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (05) : 2243 - 2260
[27] Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations
Pengyun Li
Changkai Jia
Zhiya Fan
Xiaotong Hu
Wenjuan Zhang
Ke Liu
Shiyang Sun
Haoxin Guo
Ning Yang
Maoxiang Zhu
Xiaomei Zhuang
Junhai Xiao
Zhibing Zheng
Song Li
Acta Pharmaceutica Sinica B, 2023, (06) : 2715 - 2735
[28] Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations
Li, Pengyun
Jia, Changkai
Fan, Zhiya
Hu, Xiaotong
Zhang, Wenjuan
Liu, Ke
Sun, Shiyang
Guo, Haoxin
Yang, Ning
Zhu, Maoxiang
Zhuang, Xiaomei
Xiao, Junhai
Zheng, Zhibing
Li, Song
ACTA PHARMACEUTICA SINICA B, 2023, 13 (06) : 2715 - 2735
[29] Discovery of c-Met kinase inhibitors for anticancer therapeutics.
Yun, Chang-Soo
Cho, Sung Yun
Kim, Hyoung Rae
Jung, Hee Jung
Ha, Jae D.
Lee, Kwangho
Kim, Pilho
Park, Chi Hoon
Lee, Chong Ock
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[30] Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase
Porter, John
Lumb, Simon
Lecomte, Fabien
Reuberson, James
Foley, Anne
Calmiano, Mark
le Riche, Kelly
Edwards, Helen
Delgado, Jean
Franklin, Richard J.
Gascon-Simorte, Jose M.
Maloney, Alison
Meier, Christoph
Batchelor, Mark
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (02) : 397 - 400

← 1 2 3 4 5 →